中财网 中财网股票行情
拓新药业(301089)财务分析指标    年份：
截止日期2026-03-312025-12-312025-09-302025-06-302025-03-31
营业总收入(万元)9250.2237834.3627155.3618189.989699.47
营业收入(万元)9250.2237834.3627155.3618189.989699.47
营业总成本(万元)10790.5046308.1131578.3320228.3710416.76
营业成本(万元)6997.5127854.7019182.2012512.676725.84
净利润(万元)-1050.97-6834.34-3016.11-1828.05-356.47
归属于母公司的净利润(万元)-1050.97-6966.10-3016.11-1828.05-356.47
营业利润(万元)-1342.74-7175.75-3635.82-2105.58-373.45
利润总额(万元)-1345.97-7238.54-3650.96-2143.13-396.83
少数股东损益(万元)----------
基本每股收益(元)-0.08(元)-0.55(元)-0.24(元)-0.14(元)-0.03(元)
稀释每股收益(元)-0.08(元)-0.55(元)-0.24(元)-0.14(元)-0.03(元)
非经常性损益(万元)148.88--578.18--238.79
扣除非经常性损益后净利润(万元)-1199.85-7893.81-3594.28-2220.76-595.27
总资产(万元)165097.04166529.64168936.52170723.00175169.37
总负债(万元)17607.2218111.9716700.6217299.0520273.84
归属于母公司股东权益合计(万元)147489.82148417.67152235.90153423.95154895.53
股东权益合计(万元)147489.82148417.67152235.90153423.95154895.53
实收资本(股本)(万元)12654.4512654.4512654.4512654.4512654.45
资本公积(万元)62111.0062111.0062111.0062111.0062111.00
未分配利润(万元)65726.2466777.2170727.2071915.2673386.84
经营活动产生的现金流量净额(万元)-140.95-2618.69-2278.96-2301.46-2801.05
经营活动现金流入小计(万元)8368.0231023.8124574.2016104.687406.36
经营活动现金流出小计(万元)8508.9733642.5026853.1618406.1410207.42
投资活动产生的现金流量净额(万元)846.957054.062434.031898.1211124.24
投资活动现金流入小计(万元)7534.7498499.5572891.1647257.8834188.73
投资活动现金流出小计(万元)6687.7991445.4970457.1345359.7623064.49
筹资活动产生的现金流量净额(万元)5.18-121.00-122.42----
筹资活动现金流入小计(万元)5.181.42------
筹资活动现金流出小计(万元)--122.42122.42----
期末现金及现金等价物余额(万元)11145.9110463.756195.395787.9914519.72
最后修改日期2026-04-282026-03-282025-10-292025-08-272025-04-29
↑返回页顶↑

转至拓新药业（301089）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。